📈 Jumpstart Signal Watchlist — July 29, 2026

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 At/above 3yr high $9.25 (current $9.25) · ⏳ SMA200 $5.66 (current price $9.25 is above) · 💰 Market Cap $516M
- PAYS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 80% (>20%); Revenue growth 51% (>15%); ROE 19% (>15%); Low LT D/E 0.08 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.5%)
- 🔔 Strong above EMA50 (17.9%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 64 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Paysign (NASDAQ:PAYS) Hits New 12-Month High — MarketBeat.
🤖 The stock reaching a new 52-week high is a bullish market signal and reflects strong recent momentum in $PAYS. The article also notes that analysts maintain a Moderate Buy consensus and a $10 price target, although one rating was recently lowered to Hold.
✅ Walleye Capital LLC Purchases New Shares in Paysign, Inc. — MarketBeat.
🤖 This filing-style article highlights a new institutional position in Paysign, which is typically viewed as supportive for sentiment. It also ties the move to Paysign's recent earnings beat on EPS and revenue, reinforcing the positive tone.
⚪️ Paysign EVP Joan Herman sells $517662 in company stock — Investing.com.
🤖 The insider sale can weigh on sentiment because it shows a senior executive reducing holdings, but the article says the transactions were made under a prearranged 10b5-1 plan. It also references strong Q1 results and a maintained Buy rating, which offsets some of the negative optics.
⚪️ Paysign to Host Second Quarter 2026 Earnings Call — Business Wire.
🤖 This is only a scheduling announcement for a future earnings call and does not contain results, guidance, or an analyst view. Per your instructions, it has no direct stock-impacting news content and is neutral.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: Sotera Health is a global healthcare services company that provides sterilization solutions, laboratory testing, and technical advisory services to help ensure medical and pharmaceutical products are safe for use.
- 🎯 Current $17.53 is 9% below 3yr high $19.35 · ⏳ SMA200 $16.46 (current price $17.53 is above) · 💰 Market Cap $5.0B
- SHC shows decent technicals supported by positive sentiment.

💎 Quality (Q): 43/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 280% (>20%); ROE 19% (>15%); Near-high ROE setup (52wk high + ROE); PEG ratio 0.15 (<1.5).
⏰ Entry (E): 0/20
- 📈 RSI at 53 in healthy mid-range
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Sotera Health Company (NASDAQ:SHC) Given Average Rating of "Moderate Buy" by Brokerages — MarketBeat.
🤖 Analysts covering SHC were summarized as having a consensus rating of "Moderate Buy," with 8 of 11 firms at buy and an average 1-year price target of $20.25. The article also cited Q1 2026 results that beat expectations, which supports a constructive view on the stock.
✅ What Makes Sotera Health (SHC) a Strong Position in Your Portfolio? — Yahoo Finance / O'Keeffe Stevens Advisory.
🤖 This investor-letter article highlighted Sotera Health as a portfolio candidate and pointed to its recent business performance, including Q1 2026 revenue growth of 10% year over year. The framing is favorable and reinforces positive sentiment toward SHC.
⚪️ Sotera Health Announces Second-Quarter 2026 Earnings Release Date — Yahoo Finance / Globe Newswire.
🤖 This is only a date announcement for the upcoming Q2 2026 earnings release and conference call. It does not provide results, guidance, or a new analyst view, so it is not meaningful news for the stock price.
🍭 Bonus (B): 0/10 — Misc Health & Allied Services

🏢 What they do: Ooma, Inc. provides cloud-based VoIP phone systems and unified communications services for businesses and consumers, featuring voice, messaging, video, and AI tools like call transcriptions and answering services. Their primary offerings include Ooma Office for small to mid-sized businesses, Ooma AirDial for POTS line replacement, and Ooma Telo for affordable residential landline service.
- 🎯 Current $21.88 is 1% below 3yr high $22.14 · ⏳ SMA200 $14.37 (current price $21.88 is above) · 💰 Market Cap $600M
- OOMA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (14.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1000% (>20%); Revenue growth 25% (>15%); Low LT D/E 0.50 (<1.0).
⏰ Entry (E): 2/20
- 🔔 Strong above EMA21 (8.0%)
- 🔔 Strong above EMA50 (14.8%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (mixed coverage).
✅ Ooma (NYSE:OOMA) Reaches New 1-Year High - Here's Why — MarketBeat.
🤖 The article says Ooma shares hit a new 52-week high and cites supportive analyst coverage, including repeated buy ratings and an increased price target from Lake Street. It also points to strong prior earnings and full-year guidance as reasons behind the rally.
✅ Hillsdale Investment Management Inc. Purchases New Position in Ooma, Inc. — MarketBeat.
🤖 This filing news is mildly positive because it shows a large institutional investor initiated a meaningful position in Ooma. The article also notes the stock was trading higher and that earlier earnings results beat consensus.
❌ Ooma CEO Eric Stang sells $464240 of Ooma stock — Investing.com.
🤖 The article reports insider selling by Ooma's CEO, which is typically viewed as a negative signal for sentiment. It is partially offset by discussion of strong recent quarterly results and raised outlook, so the overall impact is modestly negative.
🍭 Bonus (B): 10/10 — Computer Processing & Data Prep (Technology sector)

🏢 What they do: Exelixis is an oncology-focused biotechnology company that discovers, develops, and commercializes medicines for hard-to-treat cancers. Its main products include CABOMETYX (cabozantinib), COMETRIQ (cabozantinib), and COTELLIC (cobimetinib), and it also advances a pipeline of small molecules and biotherapeutics for cancer treatment.
- 🎯 Current $55.33 is 3% below 3yr high $57.10 · ⏳ SMA200 $45.42 (current price $55.33 is above) · 💰 Market Cap $14.0B
- EXEL shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (9.8% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 44% (>20%); ROE 43% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 53 in healthy mid-range
📢 Sentiment (S): 6/10
- 🗞️ News sentiment is positive.
✅ Exelixis (EXEL) Q2 2026 Earnings Report — MarketBeat.
🤖 This page highlights that Exelixis previously beat Q2 2025 earnings expectations and points readers to recent analyst commentary around the stock. The article is broadly supportive because it centers on ongoing earnings strength and favorable analyst coverage.
⚪️ Exelixis to Release Second Quarter 2026 Financial Results ... — Finance Yahoo / Business Wire.
🤖 Exelixis announced it will release second-quarter 2026 financial results on August 5 and hold a conference call afterward. This is a routine date announcement with no actual results, guidance, or analyst opinion, so it is neutral for the stock.
⚪️ Exelixis, Inc. (NASDAQ:EXEL) Given Consensus ... — MarketBeat.
🤖 This item reports that analysts currently assign Exelixis a consensus 'Hold' rating. It reflects stable but mixed sentiment rather than a clear catalyst, so the market impact is neutral.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workers’ compensation care, and other direct-to-employer health services.
- 🎯 Current $31.61 is 3% below 3yr high $32.69 · ⏳ SMA200 $23.27 (current price $31.61 is above) · 💰 Market Cap $4.0B
- CON shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (13.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 30% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 5/20
- 🔔 VWMA trending up (5 consecutive days)
- ⚠️ RSI reversing from overbought (59) — BEARISH
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive.
✅ William Blair initiates Concentra stock with outperform rating — Investing.com.
🤖 William Blair started coverage with an Outperform rating, which is a supportive signal for the stock. The article also points to Concentra’s strong first-quarter results and mentions other firms raising price targets, reinforcing a constructive view on $CON.
✅ Concentra Standout in Occupational Medicine: Analyst - Concentra Group Holdings (NYSE:CON) — Benzinga.
🤖 The piece highlights Concentra’s Q1 earnings beat, revenue growth, and raised fiscal 2026 sales guidance. It also notes the shares were trading near a 52-week high, which is generally favorable for investor sentiment.
⚪️ Concentra Group Holdings Parent, Inc. $CON Stake Boosted by Fifth Third Bancorp — MarketBeat.
🤖 This is mainly an ownership-filing story about a shareholder increasing its position, with no new operating update from the company. It does mention prior strong earnings and dividends, but the article itself does not introduce a fresh stock-moving catalyst.
⚪️ Hsbc Holdings PLC Buys Shares of 42927 Concentra Group Holdings Parent Inc. (CON) — MarketBeat.
🤖 This article is about institutional buying activity rather than a new company development. It repeats older earnings information and does not provide a direct operational or strategic catalyst for $CON.
🍭 Bonus (B): 0/10 — Specialty Outpatient Facilities

🏢 What they do: Terreno Realty Corporation (TRNO) is a real estate company that acquires, owns, and operates industrial properties in six major coastal U.S. markets. Its portfolio includes warehouse/distribution, flex, transshipment, and improved land properties, mainly in infill locations that serve tenant demand.
- 🎯 Current $71.74 is 4% below 3yr high $75.08 · ⏳ SMA200 $63.64 (current price $71.74 is above) · 💰 Market Cap $7.6B
- TRNO shows decent technicals supported by positive sentiment.

💎 Quality (Q): 52/60
- 🏦 Low drawdown (9.0% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 40% (>20%); Low LT D/E 0.22 (<1.0); PEG ratio 0.43 (<1.5).
⏰ Entry (E): 5/20
- 🔔 VWMA trending up (5 consecutive days)
- ⚠️ RSI reversing from overbought (56) — BEARISH
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Terreno Realty Corporation Announces Lease in Queens, NY — Yahoo Finance / Business Wire.
🤖 Terreno announced an early lease renewal for 34,000 square feet in Jamaica Queens, extending occupancy with a logistics and transportation tenant. Early renewals and continued leasing activity are generally constructive for cash flow and valuation.
✅ Terreno Realty Corporation Announces Quarterly Operating Investment and Capital Markets Activity — Business Wire.
🤖 This company update appears to cover quarterly operating, investment, and capital markets activity, which is typically material for a REIT because it can signal leasing momentum, acquisitions, and balance-sheet management. The headline suggests ongoing business execution rather than a routine calendar notice.
✅ Terreno Realty's Latest Leasing Moves: What Investors Need to Know Now — Zacks.
🤖 The article highlights multiple new and renewal leases, including Doral, Union City, Hayward, and Kearny, which support occupancy and cash-rent growth. That leasing strength is favorable for a logistics REIT like Terreno.
🍭 Bonus (B): 0/10 — Real Estate

🏢 What they do: Broadstone Net Lease, Inc. (NYSE: BNL) is an industrial-focused, diversified net lease REIT that acquires, owns, and manages primarily single-tenant commercial real estate properties that are net leased on a long-term basis to creditworthy tenants.
- 🎯 Current $22.15 is 3% below 3yr high $22.84 · ⏳ SMA200 $19.27 (current price $22.15 is above) · 💰 Market Cap $4.2B
- BNL shows decent technicals supported by positive sentiment.

💎 Quality (Q): 51/60
- 🏦 Low drawdown (8.0% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 167% (>20%); Low LT D/E 0.92 (<1.0); PEG ratio 0.20 (<1.5).
⏰ Entry (E): 5/20
- 🔔 VWMA trending up (5 consecutive days)
- ⚠️ RSI reversing from overbought (56) — BEARISH
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Broadstone Net Lease Announces Second Quarter 2026 Results — finance.yahoo.com / Business Wire.
🤖 BNL reported its second-quarter 2026 operating results and also highlighted a new joint venture that added an estimated $303 million to its committed build-to-suit pipeline. The announcement also confirmed a quarterly dividend of $0.2925 per share, which is supportive for the stock.
✅ Broadstone Net Lease (NYSE:BNL) Releases FY 2026 Earnings Guidance — MarketBeat.
🤖 The company updated full-year 2026 EPS guidance to $1.55-$1.57, which is above the cited consensus estimate of $1.52. It also followed a period of multiple bullish analyst price-target increases, reinforcing a favorable near-term tone for the shares.
✅ Broadstone Net Lease invests $303M in Colorado facility — Investing.com.
🤖 BNL announced a joint venture to develop an advanced technology facility in Colorado with an estimated total investment of about $303 million. The project’s long lease term and projected year-one cash yield of about 8.5% make it constructive for growth and future cash flow.
🍭 Bonus (B): 0/10 — REITs